XML 68 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments and Risk Management (Tables)
12 Months Ended
Dec. 31, 2013
Derivative [Line Items]  
Financial Assets and Liabilities Carried at Fair Value
Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:
 
December 31, 2013
(In thousands)
Level 1
 
Level 2
 
Level 3
 
Total
Recurring fair value measurements
 
 
 
 
 
 
 
Financial Assets
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$

 
$

 
$

 
$

Total cash equivalents

 

 

 

Trading securities:
 
 
 
 
 
 
 
Equity securities — exchange traded funds
16,622

 

 

 
16,622

Total trading securities
16,622

 

 

 
16,622

Available-for-sale fixed income investments:
 
 
 
 
 
 
 
U.S. Treasuries

 
12,827

 

 
12,827

Corporate bonds

 
10,689

 

 
10,689

Agency mortgage-backed securities

 
701

 

 
701

Other

 
2,585

 

 
2,585

Total available-for-sale fixed income investments

 
26,802

 

 
26,802

Available-for-sale equity securities:
 
 
 
 
 
 
 
Biosciences industry
204

 

 

 
204

Total available-for-sale equity securities
204

 

 

 
204

Foreign exchange derivative assets

 
6,405

 

 
6,405

Interest rate swap derivative assets

 
183,405

 

 
183,405

Purchased cash convertible note hedge

 
1,303,000

 

 
1,303,000

Total assets at recurring fair value measurement
$
16,826

 
$
1,519,612

 
$

 
$
1,536,438

Financial Liabilities
Foreign exchange derivative liabilities
$

 
$
58,485

 
$

 
$
58,485

Interest rate swap derivative liabilities

 
15,826

 

 
15,826

Cash conversion feature of Cash Convertible Notes

 
1,303,000

 

 
1,303,000

Contingent consideration

 

 
664,648

 
664,648

Total liabilities at recurring fair value measurement
$

 
$
1,377,311

 
$
664,648

 
$
2,041,959

 
December 31, 2012
(In thousands)
Level 1
 
Level 2
 
Level 3
 
Total
Recurring fair value measurements
 
 
 
 
 
 
 
Financial Assets
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
135,209

 
$

 
$

 
$
135,209

Total cash equivalents
135,209

 

 

 
135,209

Trading securities:
 
 
 
 
 
 
 
Equity securities — exchange traded funds
10,913

 

 

 
10,913

Total trading securities
10,913

 

 

 
10,913

Available-for-sale fixed income investments:
 
 
 
 
 
 
 
U.S. Treasuries

 
11,085

 

 
11,085

Corporate bonds

 
8,189

 

 
8,189

Agency mortgage-backed securities

 
1,050

 

 
1,050

Other

 
2,502

 

 
2,502

Total available-for-sale fixed income investments

 
22,826

 

 
22,826

Available-for-sale equity securities:
 
 
 
 
 
 
 
Biosciences industry
102

 

 

 
102

Total available-for-sale equity securities
102

 

 

 
102

Foreign exchange derivative assets

 
5,818

 

 
5,818

Interest rate swap derivative assets

 
36,647

 

 
36,647

Purchased cash convertible note hedge

 
636,300

 

 
636,300

Total assets at recurring fair value measurement
$
146,224

 
$
701,591

 
$

 
$
847,815

Financial Liabilities
Foreign exchange derivative liabilities
$

 
$
19,228

 
$

 
$
19,228

Interest rate swap derivative liabilities

 
9,823

 

 
9,823

Cash conversion feature of Cash Convertible Notes

 
636,300

 

 
636,300

Contingent consideration

 

 
379,197

 
379,197

Total liabilities at recurring fair value measurement
$

 
$
665,351

 
$
379,197

 
$
1,044,548

 
Schedule of Available-for-Sale Securities Reconciliation
The amortized cost and estimated fair value of available-for-sale securities, included in prepaid expenses and other current assets, were as follows:
 
(In thousands)
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
December 31, 2013
 
 
 
 
 
 
 
Debt securities
$
26,533

 
$
286

 
$
(17
)
 
$
26,802

Equity securities

 
204

 

 
204

 
$
26,533

 
$
490

 
$
(17
)
 
$
27,006

December 31, 2012
 
 
 
 
 
 
 
Debt securities
$
21,276

 
$
1,550

 
$

 
$
22,826

Equity securities

 
102

 

 
102

 
$
21,276

 
$
1,652

 
$

 
$
22,928

Maturities Of Available-for-Sale Debt Securities At Fair Value
Maturities of available-for-sale debt securities at fair value as of December 31, 2013, were as follows:
 
(In thousands)
 
Mature within one year
$
605

Mature in one to five years
10,254

Mature in five years and later
15,943

 
$
26,802



Fair Value Hedging Relationships
 
Derivative [Line Items]  
Effect of Derivative Instruments on the Consolidated Statements of Operations
The Effect of Derivative Instruments on the Consolidated Statements of Operations
Derivatives in Fair Value Hedging Relationships
 
Location of (Loss) or Gain Recognized in Earnings on Derivatives
 
Amount of (Loss) or Gain Recognized in Earnings on Derivatives
 
Year Ended December 31,
(In thousands)
2013
 
2012
 
2011
Interest rate swaps
Interest expense
 
$
(17,933
)
 
$
19,562

 
$
42,648

Total
 
$
(17,933
)
 
$
19,562

 
$
42,648

 
 
Location of Gain or (Loss) Recognized in Earnings on Hedged Items
 
Amount of Gain or (Loss) Recognized in Earnings on Hedging Items
 
Year Ended December 31,
(In thousands)
2013
 
2012
 
2011
2016 Senior Notes (1.800% coupon)
Interest expense
 
$
448

 
$

 
$

2018 Senior Notes (6.000% coupon)
Interest expense
 
17,073

 
(6,873
)
 
(29,773
)
2023 Senior Notes (3.125% coupon)
Interest expense
 
15,379

 

 

Total
 
$
32,900

 
$
(6,873
)
 
$
(29,773
)
Cash Flow Hedging Relationships
 
Derivative [Line Items]  
Effect of Derivative Instruments on the Consolidated Statements of Operations
The Effect of Derivative Instruments on the Consolidated Statements of Operations
Derivatives in Cash Flow Hedging Relationships
 
 
Amount of (Loss) or Gain
Recognized in AOCE (Net of Tax)
on Derivative
(Effective Portion)
 
 
Year Ended December 31,
(In thousands)
 
2013
 
2012
 
2011
Foreign currency forward contracts
 
$
(83,784
)
 
$
(25,536
)
 
$
(55,453
)
Interest rate swaps
 
136,616

 
(8,168
)
 
15,836

  Total
 
$
52,832

 
$
(33,704
)
 
$
(39,617
)
 
 
Location of Loss Reclassified from AOCE into Earnings (Effective Portion)
 
Amount of Loss
Reclassified from AOCE
into Earnings
(Effective Portion)
 
Year Ended December 31,
(In thousands)
2013
 
2012
 
2011
Foreign currency forward contracts
Net revenues
 
$
(60,493
)
 
$
(44,217
)
 
$
(5,492
)
Interest rate swaps
Interest expense
 
(1,465
)
 
(2,386
)
 
(15,719
)
Interest rate swaps
Other (expense) income, net
 
(818
)
 

 

  Total
 
$
(62,776
)
 
$
(46,603
)
 
$
(21,211
)

 
Location of Gain Excluded from the Assessment of Hedge Effectiveness
 
Amount of Gain
Excluded from the Assessment
of Hedge Effectiveness
 
Year Ended December 31,
(In thousands)
2013
 
2012
 
2011
Foreign currency forward contracts
Other (expense) income, net
 
$
61,636

 
$
58,024

 
$
13,432

  Total
 
$
61,636

 
$
58,024

 
$
13,432

Net Investment Hedging Relationships
 
Derivative [Line Items]  
Effect of Derivative Instruments on the Consolidated Statements of Operations
The Effect of Derivative Instruments on the Consolidated Statements of Operations
Derivatives in Net Investment Hedging Relationships
 
 
Amount of Loss
Recognized in AOCE (Net of Tax)
on Derivative
(Effective Portion)
 
 
Year Ended December 31,
(In thousands)
 
2013
 
2012
 
2011
Foreign currency borrowings
 
$

 
$

 
$
(11,596
)
  Total
 
$

 
$

 
$
(11,596
)
Designated as Hedging Instrument
 
Derivative [Line Items]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
Fair Values of Derivative Instruments
Derivatives Designated as Hedging Instruments
 
Asset Derivatives
 
December 31, 2013
 
December 31, 2012
(In thousands)
Balance Sheet Location
 
Fair Value
 
Balance Sheet Location
 
Fair Value
Interest rate swaps
Prepaid expenses and other current assets
 
$
90,305

 
Prepaid expenses and other current assets
 
$
36,647

Interest rate swaps
Other assets
 
93,100

 
Other assets
 

Total
 
$
183,405

 
 
 
$
36,647


 
Liability Derivatives
 
December 31, 2013
 
December 31, 2012
(In thousands)
Balance Sheet Location
 
Fair Value
 
Balance Sheet Location
 
Fair Value
Interest rate swaps
Other current liabilities
 
$
15,826

 
Other current liabilities
 
$
9,823

Foreign currency forward contracts
Other current liabilities
 
53,123

 
Other current liabilities
 
15,863

Total
 
$
68,949

 
 
 
$
25,686

Not Designated as Hedging Instrument
 
Derivative [Line Items]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
Fair Values of Derivative Instruments
Derivatives Not Designated as Hedging Instruments
 
Asset Derivatives
 
December 31, 2013
 
December 31, 2012
(In thousands)
Balance Sheet Location
 
Fair Value
 
Balance Sheet Location
 
Fair Value
Foreign currency forward contracts
Prepaid expenses and other current assets
 
$
6,405

 
Prepaid expenses and other current assets
 
$
5,818

Purchased cash convertible note hedge
Other assets
 
1,303,000

 
Other assets
 
636,300

Total
 
$
1,309,405

 
 
 
$
642,118

 
Liability Derivatives
 
December 31, 2013
 
December 31, 2012
(In thousands)
Balance Sheet Location
 
Fair Value
 
Balance Sheet Location
 
Fair Value
Foreign currency forward contracts
Other current liabilities
 
$
5,362

 
Other current liabilities
 
$
3,365

Cash conversion feature of Cash Convertible Notes
Long-term debt
 
1,303,000

 
Long-term debt
 
636,300

Total
 
$
1,308,362

 
 
 
$
639,665

Effect of Derivative Instruments on the Consolidated Statements of Operations
The Effect of Derivative Instruments on the Consolidated Statements of Operations
Derivatives Not Designated as Hedging Instruments
 
 
Location of Gain
or (Loss)
Recognized
in Earnings
on Derivatives
 
Amount of Gain or (Loss)
Recognized in Earnings on
Derivatives
 
Year Ended December 31,
(In thousands)
2013
 
2012
 
2011
Foreign currency forward contracts
Other (expense) income, net
 
$
2,173

 
$
(8,429
)
 
$
20,740

Cash conversion feature of Cash Convertible Notes
Other (expense) income, net
 
(667,000
)
 
$
(176,300
)
 
$
12,400

Purchased cash convertible note hedge
Other (expense) income, net
 
667,000

 
$
176,300

 
$
(12,400
)
  Total
 
$
2,173

 
$
(8,429
)
 
$
20,740